One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster Virus (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic Cell Transplant (HCT) Recipients

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Varicella-Zoster Virus Hepatitis and a Suggested Management Plan for Prevention of VZV Infection in Adult Liver Transplant Recipients

Transplantation
Transplantation
1995English

Varicella-Zoster-Virus (VZV)

2009English

Varicella-Zoster Virus (VZV)

English

Characteristics of Varicella Zoster (Vzv) Virus

Vojenske Zdravotnicke Listy
ImmunologyPharmacologyEmergency MedicinePublic HealthVeterinaryMicrobiology EnvironmentalEmergency Medical ServicesToxicologyPharmaceuticsOccupational Health
2016English

Immunogenicity of Varicella Zoster Virus Glycoprotein E DNA Vaccine

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Impact of Varicella Vaccine on Varicella-Zoster Virus Dynamics

Clinical Microbiology Reviews
ImmunologyEnvironmentalPublic HealthMicrobiologyMicrobiology EpidemiologyInfectious DiseasesOccupational Health
2010English

Comparison of Two Methods for Detecting Varicella-Zoster Virus Antibody With Varicella-Zoster Virus Cell-Mediated Immunity.

Journal of Clinical Microbiology
Microbiology
1996English

Cases of Laryngeal Paralysis Caused by the Varicella-Zoster Virus (VZV)

Practica Otologica, Supplement
Otorhinolaryngology
2014English

Vaccination of Hematopoietic Cell Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy